<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Prie H</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Analysis the outcomes of &lt;i>Pseudomonas aeruginosa&lt;/i> prosthetic joint infection (PJI), and of their clinical and microbiological characteristics, surgical strategies and antibiotic treatments.&lt;h4>Methods&lt;/h4>Monocenter cohort study in a Bone-and-Joint-Infection Referral Center (08/2004 to 10/2018) including all consecutive &lt;i>P. aeruginosa&lt;/i> PJIs. Data were extracted from the prospective database, including the following events: relapses, new PJIs, related deaths.&lt;h4>Results&lt;/h4>Median [IQR]: among the 43 patients included (28 females; 72 [63-80] years old; 27 hip, 15 knee, and 1 shoulder PJIs), 29 (67%) had underlying comorbidities, 12 (28%) had previously been treated for another PJI and 9 (21%) had undergone previous surgeries for their &lt;i>P. aeruginosa&lt;/i> PJI. E</pubmed_abstract><journal>Frontiers in medicine</journal><pagination>1039596</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9774483</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>&lt;i>Pseudomonas aeruginosa&lt;/i> prosthetic joint-infection outcomes: Prospective, observational study on 43 patients.</pubmed_title><pmcid>PMC9774483</pmcid><pubmed_authors>Meyssonnier V</pubmed_authors><pubmed_authors>Zeller V</pubmed_authors><pubmed_authors>Marmor S</pubmed_authors><pubmed_authors>Heym B</pubmed_authors><pubmed_authors>Lidove O</pubmed_authors><pubmed_authors>Kerroumi Y</pubmed_authors><pubmed_authors>Prie H</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>Pseudomonas aeruginosa&lt;/i> prosthetic joint-infection outcomes: Prospective, observational study on 43 patients.</name><description>&lt;h4>Objectives&lt;/h4>Analysis the outcomes of &lt;i>Pseudomonas aeruginosa&lt;/i> prosthetic joint infection (PJI), and of their clinical and microbiological characteristics, surgical strategies and antibiotic treatments.&lt;h4>Methods&lt;/h4>Monocenter cohort study in a Bone-and-Joint-Infection Referral Center (08/2004 to 10/2018) including all consecutive &lt;i>P. aeruginosa&lt;/i> PJIs. Data were extracted from the prospective database, including the following events: relapses, new PJIs, related deaths.&lt;h4>Results&lt;/h4>Median [IQR]: among the 43 patients included (28 females; 72 [63-80] years old; 27 hip, 15 knee, and 1 shoulder PJIs), 29 (67%) had underlying comorbidities, 12 (28%) had previously been treated for another PJI and 9 (21%) had undergone previous surgeries for their &lt;i>P. aeruginosa&lt;/i> PJI. E</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-05T14:57:42.573Z</modification><creation>2025-04-05T14:57:42.573Z</creation></dates><accession>S-EPMC9774483</accession><cross_references><pubmed>36569155</pubmed><doi>10.3389/fmed.2022.1039596</doi></cross_references></HashMap>